Ling Ma

1.7k total citations
41 papers, 438 citations indexed

About

Ling Ma is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Ling Ma has authored 41 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 20 papers in Virology and 9 papers in Molecular Biology. Recurrent topics in Ling Ma's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (20 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Ling Ma is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (20 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Ling Ma collaborates with scholars based in China, Canada and Portugal. Ling Ma's co-authors include Shan Cen, Jinming Zhou, Fei Guo, Xiaoyu Li, Zhenlong Liu, Juxian Wang, Dongrong Yi, Quanjie Li, Guoning Zhang and Biao Dong and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Ling Ma

35 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Ma China 13 199 125 125 97 69 41 438
Siwaporn Boonyasuppayakorn Thailand 14 126 0.6× 64 0.5× 105 0.8× 65 0.7× 90 1.3× 41 531
G.J. Lockbaum United States 13 250 1.3× 86 0.7× 164 1.3× 87 0.9× 167 2.4× 21 448
Tianhong Zhang China 12 174 0.9× 62 0.5× 159 1.3× 70 0.7× 49 0.7× 13 420
M. Narwal India 9 172 0.9× 50 0.4× 102 0.8× 54 0.6× 105 1.5× 12 363
Manisha Saini India 13 140 0.7× 28 0.2× 117 0.9× 69 0.7× 25 0.4× 31 445
André S. Godoy Brazil 16 242 1.2× 40 0.3× 294 2.4× 32 0.3× 155 2.2× 38 672
Jean Ndjomou United States 12 192 1.0× 60 0.5× 201 1.6× 142 1.5× 35 0.5× 22 667
Andrea Astolfi Italy 14 111 0.6× 102 0.8× 229 1.8× 18 0.2× 66 1.0× 25 394
Supriya Sharma India 11 75 0.4× 115 0.9× 79 0.6× 8 0.1× 58 0.8× 45 438
Haozhou Tan United States 13 427 2.1× 142 1.1× 229 1.8× 32 0.3× 339 4.9× 27 700

Countries citing papers authored by Ling Ma

Since Specialization
Citations

This map shows the geographic impact of Ling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ma more than expected).

Fields of papers citing papers by Ling Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ma. The network helps show where Ling Ma may publish in the future.

Co-authorship network of co-authors of Ling Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Ma. A scholar is included among the top collaborators of Ling Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Ma. Ling Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shumin, Ling Ma, Zhen Wang, et al.. (2025). SLFN14 functions as a P-TEFb inhibitor to modulate the transcription of HIV-1 and cellular genes. Science Advances. 11(51). eadt7982–eadt7982.
2.
3.
4.
Zhao, Jian‐Yuan, Guoning Zhang, Yasheng Li, et al.. (2025). Discovery and optimization of phenazopyridine hydrochloride as novel SARS-CoV-2 RdRp inhibitors. European Journal of Medicinal Chemistry. 288. 117422–117422.
5.
Gao, Yu, Qingqing Yang, Ling Ma, et al.. (2025). Rational design, synthesis, and evaluating primary biological activities of novel HIV-1 protease inhibitors containing heteraryl acetamides as the P2 ligands. Bioorganic & Medicinal Chemistry. 129. 118338–118338.
6.
Liu, Qian, Dongrong Yi, Jiwei Ding, et al.. (2023). MOV10 recruits DCP2 to decap human LINE ‐1 RNA by forming large cytoplasmic granules with phase separation properties. EMBO Reports. 24(9). e56512–e56512. 7 indexed citations
7.
Zhou, Huiyu, Ling Ma, Biao Dong, et al.. (2022). Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C. European Journal of Medicinal Chemistry. 233. 114251–114251. 6 indexed citations
8.
Ma, Ling, Biao Dong, Juxian Wang, et al.. (2022). Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 246. 114981–114981. 6 indexed citations
9.
Zhang, Zixiong, Ning Zhang, Qian Liu, et al.. (2022). The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition. Frontiers in Microbiology. 13. 891852–891852. 1 indexed citations
10.
Zhao, Jian‐Yuan, Dongrong Yi, Quanjie Li, et al.. (2022). 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis. Antiviral Research. 198. 105254–105254. 13 indexed citations
11.
Ma, Ling, Quanjie Li, Jian‐Yuan Zhao, et al.. (2022). Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro. Antiviral Research. 207. 105419–105419. 14 indexed citations
12.
Ma, Ling, Biao Dong, Jinming Zhou, et al.. (2022). A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants. Bioorganic & Medicinal Chemistry. 64. 116760–116760. 3 indexed citations
13.
Guo, Saisai, Xiaobo Lei, Yan Chang, et al.. (2022). SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. Signal Transduction and Targeted Therapy. 7(1). 400–400. 11 indexed citations
14.
Zhou, Huiyu, Ling Ma, Biao Dong, et al.. (2021). Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants. European Journal of Medicinal Chemistry. 220. 113450–113450. 19 indexed citations
15.
Zhao, Jian‐Yuan, Guoning Zhang, Yongxin Zhang, et al.. (2021). 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. Antiviral Research. 196. 105209–105209. 11 indexed citations
16.
Zhao, Jian‐Yuan, Saisai Guo, Dongrong Yi, et al.. (2021). A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral Research. 190. 105078–105078. 62 indexed citations
17.
18.
Ma, Ling, Huiyu Zhou, Biao Dong, et al.. (2019). Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants. European Journal of Medicinal Chemistry. 185. 111866–111866. 24 indexed citations
19.
Zhang, Quan, Zeyun Mi, Yuming Huang, et al.. (2016). 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation. Retrovirology. 13(1). 13–13. 12 indexed citations
20.
Mi, Zeyun, Jiwei Ding, Quan Zhang, et al.. (2015). A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2. Scientific Reports. 5(1). 18499–18499. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siwaporn Boonyasuppayakorn Breakdown of academic impact, for papers by G.J. Lockbaum Breakdown of academic impact, for papers by Tianhong Zhang Breakdown of academic impact, for papers by M. Narwal Breakdown of academic impact, for papers by Manisha Saini Breakdown of academic impact, for papers by André S. Godoy Breakdown of academic impact, for papers by Jean Ndjomou Breakdown of academic impact, for papers by Andrea Astolfi Breakdown of academic impact, for papers by Supriya Sharma Breakdown of academic impact, for papers by Haozhou Tan
Rankless by CCL
2026